发明授权
US5665741A 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of
neuronal diseases
失效
1,4-二氢吡啶-3,5-二羧酸酯治疗神经元疾病
- 专利标题： 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases
- 专利标题（中）： 1,4-二氢吡啶-3,5-二羧酸酯治疗神经元疾病
-
申请号： US516668申请日： 1995-08-18
-
公开(公告)号： US5665741A公开(公告)日： 1997-09-09
- 发明人: Klaus Urbahns , Otto Behner , Siegfried Goldmann , Hans-Georg Heine , Bodo Junge , Rudolf Schohe-Loop , Egbert Wehinger , Hartmund Wollweber , Henning Sommermeyer , Thomas Glaser , Reilinde Wittka , Jean-Marie-Viktor de Vry
- 申请人： Klaus Urbahns , Otto Behner , Siegfried Goldmann , Hans-Georg Heine , Bodo Junge , Rudolf Schohe-Loop , Egbert Wehinger , Hartmund Wollweber , Henning Sommermeyer , Thomas Glaser , Reilinde Wittka , Jean-Marie-Viktor de Vry
- 申请人地址： DEX Leverkusen
- 专利权人： Bayer Aktiengesellschaft
- 当前专利权人： Bayer Aktiengesellschaft
- 当前专利权人地址： DEX Leverkusen
- 优先权： DEX4430094.8 19940825
- 主分类号： A61K31/435
- IPC分类号： A61K31/435 ; A61K31/44 ; A61K31/4427 ; A61P9/10 ; A61P25/00 ; A61P43/00 ; C07D211/90 ; C07D401/04
摘要：
The present invention relates to the use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters, some of which are known, of the general formula (I) ##STR1## in which A and R.sup.1 -R.sup.3 have the meaning given in the description, as medicaments, in particular for treatment of the central nervous system, and new selected active compounds.
公开/授权文献
- US5208742A Data line monitoring system 公开/授权日：1993-05-04